global hiv vaccine enterprise annual stakeholders meeting: accelerating early phase vaccine research
Published 1 year ago • 602 plays • Length 3:11:24Download video MP4
Download video MP3
Similar videos
-
3:51:08
global hiv vaccine enterprise annual stakeholder meeting: hiv vaccine cannot be ‘business as usual’
-
56:51
ve-panel 2b: future design approaches for hiv vaccine efficacy trials
-
25:27
hivr4p // virtual sa03 hiv & tb: an r&d tale of two vaccines (part 1/3)
-
1:29:06
webinar 02 – experimental medicine trials for hiv research
-
1:02:07
ve-panel 3b: community engagement and involvement in hiv vaccine prevention clinical research
-
1:29:48
swinging into full gear: strengthening industry engagement in hiv vaccine research and development
-
19:38
hivr4p // virtual 2021 (sa16) how hiv vaccine r&d is enabling the rapid covid-19 vaccine response
-
23:37
w26052107 gene signature associating with hiv vaccine efficacy and antibody effector function
-
20:16
hivr4p // virtual sa03 hiv & tb: an r&d tale of two vaccines (part 3/3)
-
25:21
hivr4p // virtual sa03 hiv & tb: an r&d tale of two vaccines (part 2/3)
-
58:40
ve-panel 2c: research pathway for the use of monoclonal antibodies in hiv prevention.
-
57:54
ve panel 1: design approaches for current and future hiv prevention efficacy trials
-
1:35
what to expect at hivr4p // virtual
-
13:31
s2-07: vrc01 antibody prevention of hiv
-
10:54
w26052102 imbokodo & mosaico updates, plans for correlates and sieve analyses.
-
28:50
s3-04: evaluating an hiv vaccine efficacy vs. counterfactual placebo: immune mediator approach
-
1:31
hiv unmuted - the ias podcast trailer
-
14:55
s2-04: using of a surrogate endpoint in licensure of pneumococcal vaccines (david radley)
-
3:25
s1-01: introduction to the workshop (roger tatoud)